| Esophageal and Gastroesophageal Junction Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived144 of 144show fewer |
|---|
| → investigated in trials for | Fluorouracilsmall molecule 98 trials (41 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 98 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 96 trials (45 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 96 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 96 trials (44 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 96 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 80 trials (28 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 80 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 76 trials (26 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 76 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 66 trials (32 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 52 trials (20 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 48 trials (15 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 48 trials (22 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 38 trials (20 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 36 trials (19 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 35 trials (21 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 30 trials (17 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 27 trials (10 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 27 trials (14 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 24 trials (11 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 23 trials (15 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 21 trials (6 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 18 trials (9 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 16 trials (6 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nimotuzumabmonoclonal antibody 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 11 trials (9 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 8 trials (8 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 7 trials (6 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Levoleucovorinsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nedaplatinsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tegafursmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tucatinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hyperthermic Intraperitoneal Chemotherapy 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Catumaxomabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Icotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Infigratinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxel Liposome 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Raltitrexedsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | CAPOX Regimen 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin OR Cisplatin 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ceritinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Derazantinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX-6 Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Margetuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | PD1 Inhibitor 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumab/Trastuzumab Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porcupine Inhibitor WNT974 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pyrotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rigosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rilotumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Savolitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taselisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Deruxtecanadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Deruxtecan Regimen 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zolbetuximabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zongertinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Esophageal and Gastroesophageal Junction Carcinoma | 1 | Observed | clinicaltrials | graph → |